Target intelligence / Profile preview

Intraflagellar transport protein 88 homolog (IFT88)

Target
IFT88
Molecular classification
Structural protein, Intraflagellar transport complex component (IFT-B subcomplex), Tetratricopeptide repeat (TPR) family protein
01

Overview

Intraflagellar transport protein 88 homolog (**IFT88**) is a core component of the **intraflagellar transport-B (IFT-B) complex**, required for the formation and maintenance of cilia and flagella in eukaryotic cells[1][3]. As a member of the tetratricopeptide repeat (TPR) family, IFT88 mediates assembly of macromolecular complexes that shuttle structural and signaling proteins along ciliary and flagellar axonemes, primarily by interacting with other IFT-B proteins such as IFT52 and IFT70, and with motor proteins like kinesin-2 for anterograde movement[3][4][6]. IFT88 is indispensable for ciliogenesis; its absence results in failure to form functional cilia and flagella, underlying a range of **ciliopathies** such as polycystic kidney disease and congenital anosmia[1][2][5]. Beyond ciliary roles, IFT88 regulates cell cycle progression, ensuring proper spindle orientation and planar cell polarity in dividing cells[1][2]. Mutations or silencing of IFT88 disrupt essential signaling pathways within the cilium, leading to defects in organ development, neural function, and tissue homeostasis, particularly affecting kidney, cartilage, and neural tissue[1][5][6]. Animal models and cell studies demonstrate that loss of IFT88 impairs cilia length and function, confirming its status as a critical structural and regulatory protein but not a classical druggable target[4]. IFT88 serves as a molecular marker in experimental studies for ciliary diseases and is commonly used to investigate the mechanism of ciliogenesis and centrosome-cilia cross-talk in development and disease[1][3][4][6].

Other names
PolarisTG737TTC10TPR repeat protein 10hTg737D13S1056EMGC26259Recessive polycystic kidney disease protein Tg737 homologTetratricopeptide repeat protein 10DAF19Testicular tissue protein Li 93Tetratricopeptide repeat domain 10
02

Mechanism of action

Not applicable; there are no drugs currently known to act on IFT88

03

Biological functions

Ciliogenesis (formation and maintenance of cilia and flagella)Flagellar assembly (especially in organisms like *Chlamydomonas* and *Giardia*)Regulation of cell cycle (including G1-S transition in non-ciliated cells)Spindle orientation and planar cell polarity establishment in dividing cellsSignal transduction (via primary cilium roles)Metabolic regulationChondrocyte developmentActin organization (cilium-independent function)Sensory reception (primary cilia act as mechanosensors and chemosensors)Neurological functions
04

Disease associations

Ciliopathies (broad spectrum of diseases affecting cilia)Polycystic kidney diseaseOrgan fibrosis and cyst formationDisorders of metabolic regulation and cartilage degenerationAnosmia (loss of smell due to cilia defects)Neurodevelopmental disorders (related to ciliary and centrosomal dysfunction)
05

Safety considerations

Not a drug target, so no direct safety concerns are associated with pharmacologic modulation; however, loss of IFT88 function is deleterious and causes severe developmental and organ defectsTherapeutic challenges: Ciliary dysfunction resulting from genetic or epigenetic alteration of IFT88 causes multisystem diseases (e.g., polycystic kidney disease, syndromic ciliopathies)
06

Biomarkers

IFT88 gene/protein levels can be biomarkers for ciliopathies such as polycystic kidney diseaseDecreased IFT88 expression is associated with shortened or defective cilia in cell models

Beyond the preview

Go deeper on Intraflagellar transport protein 88 homolog (IFT88).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intraflagellar transport protein 88 homolog (IFT88).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call